P- 28 ATORVASTATIN SHOWS ANTI-PROMOTOR AND ANTI-NEOANGIOGENIC EFFECT IN HEPATOCELLULAR CARCINOMA DEVELOPMENT IN VIVO AND IN VITRO MODEL BY INHIBITING TGF-ß1/pERK SIGNALING PATHWAY Ezequiel Ridruejo; Zahira Deza; Giselle Romero Caimi; Lucia Coli; AndLaura Alvarez;

Evaluation of four chatbots in autoimmune liver disease: A comparative analysis Jimmy Daza; Lucas Soares Bezerra; Laura Santamaría; Roberto Rueda-Esteban; Heike Bantel; Marcos Girala; Matthias Ebert; Florian Van Bömmel; Andreas Geier; Andres Gomez Aldana; Kevin Yau; Mario Alvares-da-Silva; Markus Peck-Radosavljevic; Ezequiel Ridruejo; Arndt Weinmann; Andreas Teufel;

P-9 AUTOIMMUNE LIVER DISEASES IN LATIN AMERICA: A WEB-BASED SURVEY Claudia Alves; Guilherme Grossi Lopes; Debora Raquel B; Eduardo Luiz Rachid; Daniela Chiodi; Javier Brahm; Carlos Bernardo Sánchez; Manuel Gatica; Carmen Pollio; Juan Diego De La Cruz; Ezequiel Ridruejo; Marcos Girala; Zuly Plácido; Martin Padilla; Gabriel Sebastian Diaz; Gustavo Bresky; Julissa Lombardo; Diana Torres; Harlim Rodriguez; Melisa Dirchwolf; Juanita Pérez; Lesvia Arrunategui; Nicolás Lama; Fátima Higuera; Cristiane Villela; Mario Reis; Walter Barriga; Gonzalo Araneda; Gisela Gualano; Pedro Andrés Montes; Vivian Rotman; Rodolfo Antonio Ortiz; Patricia Guerra; Juan Antonio Otegui; Alejandro Ferrada; Maria Laura Garrido; Mauricio Carrasco; Alma Kuljacha; Marco Sánchez; Graciela Castro; Viridiana López; Ana Alicia Martínez; Ruth González; Gustavo Henrique; Eira Cerda; Alejandro Soza; Mirta Peralta; Diego Arufe; Fernando Gómez; Gustavo Calle; Carlos García; Scherezada Mejia; Santiago Rodríguez; Nicolas Jaquin Fernandez; María Noel García; Mario Guimaraes;